Alice Di Rocco

18PUBLICATIONS

138CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursRespiratory diseases

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (18)

Sort by Publication Date:

|Jun 17, 2026

Metabolic heterogeneity-based radiomic model predicts treatment outcomes of primary mediastinal B-cell lymphoma patients in the IELSG37 study.

|May 05, 2026

Polatuzumab vedotin-containing regimens as bridge to CART: analysis from the CART-SIE study.

|Nov 28, 2025

Managing Treatment-Emergent Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome Following CAR-T Cell Therapy: A Case-Based Review of the use of Emapalumab.

Livia Donzelli, Veronica Zullino, Giovanni Fernando Torelli

|Sep 12, 2025

Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial.

Emanuele Zucca, Luca Ceriani, Giovannino Ciccone

|Aug 08, 2025

Routine prophylaxis with levetiracetam offers no benefit in CD19 CAR-T for LBCL: a multicenter propensity-matched study.

Eugenio Galli, Roberta Di Blasi, Alice Di Rocco

|Aug 05, 2025

Outcomes of CAR T-cell therapy in high-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysis.

Anna Dodero, Giusy Ceparano, Beatrice Casadei

Pageof 3

Frequent Collaborators

Federico Stella

Carlo Visco

Patrizia Chiusolo

Mauro Krampera

Stefan Hohaus

Livia Donzelli

Annalisa Chiappella

Ilaria Cutini

Simone Ferrero

Monica Balzarotti

Frequent Collaborators

Federico Stella

Carlo Visco

Patrizia Chiusolo

Mauro Krampera